United States — Food and Drug Administration & Vinay Prasad

United States — Food and Drug Administration: The United States — Food and Drug Administration (FDA) is the regulatory body responsible for approving the mFlusiva vaccine. Its advisory committee's unanimous recommendation is a crucial step towards the vaccine's market entry, despite internal disputes and leadership vacancies.

Vinay Prasad: Dr. Vinay Prasad, a former top United States — Food and Drug Administration official, initially blocked Moderna's application, raising concerns about the comparator vaccine used in trials. His actions highlighted heightened scrutiny but were ultimately challenged and overturned.

Vinay Prasad: As a top deputy at the United States — Food and Drug Administration, Vinay Prasad co-authored the New England Journal of Medicine piece announcing the change in drug approval requirements. However, he has also taken a more restrictive approach to vaccines and gene therapies, creating some inconsistency.

Vinay Prasad: Dr. Vinay Prasad, director of the United States — Food and Drug Administration's Center for Biologics Evaluation and Research, initially overruled agency reviewers and signed the refusal letter for Moderna's vaccine application, citing concerns about the trial's control arm.

Vinay Prasad: Dr. Vinay Prasad, the United States — Food and Drug Administration vaccine director, issued the refusal-to-file letter to Moderna, citing issues with its clinical trial methodology.

Vinay Prasad: Vinay Prasad, the United States — Food and Drug Administration's vaccine chief who advocated for placebo-controlled trials, is leaving the agency, which might influence future regulatory approaches.

Vinay Prasad: Vinay Prasad, the United States — Food and Drug Administration's vaccine and biotech chief, stepped down amid criticism, having co-written papers with Tracy Beth Høeg and Marty Makary.

Vinay Prasad: Vinay Prasad>>>, a close ally of Marty Makary>>>, served as the FDA's vaccine and biotech chief but was pushed out twice, contributing to the agency's internal dysfunction and leadership instability.